dc.contributor.author | Giobbie-Hurder, Anita | |
dc.contributor.author | Gelber, Richard D. | |
dc.contributor.author | Price, Karen N. | |
dc.date.accessioned | 2022-02-18T10:57:41Z | |
dc.date.available | 2022-02-18T10:57:41Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Giobbie-Hurder A., Price K. N. , Gelber R. D. , "Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer", CLINICAL TRIALS, cilt.6, sa.3, ss.272-287, 2009 | |
dc.identifier.issn | 1740-7745 | |
dc.identifier.other | av_cb45894f-c696-496a-8fe0-afab320a70fc | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/180245 | |
dc.identifier.uri | https://doi.org/10.1177/1740774509105380 | |
dc.description.abstract | Background Aromatase inhibitors provide superior disease control when compared with tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer. | |
dc.language.iso | eng | |
dc.subject | Research and Theory | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Reviews and References (medical) | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.title | Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer | |
dc.type | Makale | |
dc.relation.journal | CLINICAL TRIALS | |
dc.contributor.department | Harvard University , , | |
dc.identifier.volume | 6 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 272 | |
dc.identifier.endpage | 287 | |
dc.contributor.firstauthorID | 3376806 | |